BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 17823884)

  • 21. [Can we treat with modern antirheumatics? Costs of NSAID treatment].
    Bolten WW
    Pharm Unserer Zeit; 2002; 31(2):206-15. PubMed ID: 11977457
    [No Abstract]   [Full Text] [Related]  

  • 22. DMARDS and infections in rheumatoid arthritis.
    Caporali R; Caprioli M; Bobbio-Pallavicini F; Montecucco C
    Autoimmun Rev; 2008 Dec; 8(2):139-43. PubMed ID: 19014871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Joint approach.
    Palmer K
    Minn Med; 2009 Sep; 92(9):22-5. PubMed ID: 19877473
    [No Abstract]   [Full Text] [Related]  

  • 24. Guidelines for use of antirheumatic drugs.
    Russell AS; Darmawan J; Scott DL; Brooks PM; Hubscher O
    J Rheumatol Suppl; 1994 Sep; 41():79-81. PubMed ID: 7799391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of methotrexate in childhood rheumatic diseases.
    Wallace CA
    Arthritis Rheum; 1998 Mar; 41(3):381-91. PubMed ID: 9506564
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacogenetics in the rheumatic diseases, from prêt-à-porter to haute couture.
    Cronstein BN
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):2-3. PubMed ID: 16932642
    [No Abstract]   [Full Text] [Related]  

  • 27. Safety issues of biologics in pregnant patients with rheumatic diseases.
    Ostensen M
    Ann N Y Acad Sci; 2014 May; 1317():32-8. PubMed ID: 24840548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical therapeutics.
    Robinson DR
    Curr Opin Rheumatol; 1999 May; 11(3):159-60. PubMed ID: 10328572
    [No Abstract]   [Full Text] [Related]  

  • 29. The British Society for Rheumatology Biologics Register: 6 years on.
    Hyrich KL; Watson KD; Isenberg DA; Symmons DP;
    Rheumatology (Oxford); 2008 Oct; 47(10):1441-3. PubMed ID: 18596052
    [No Abstract]   [Full Text] [Related]  

  • 30. [Positive and negative effects of cytostatic therapy in rheumatic patients].
    Krampac I
    Reumatizam; 1970; 17(2):51-4. PubMed ID: 5311483
    [No Abstract]   [Full Text] [Related]  

  • 31. Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNFalpha) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases, 2004.
    Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Bijlsma JW; Dougados M; Emery P; Keystone EC; Klareskog L; Mease PJ
    Ann Rheum Dis; 2004 Nov; 63 Suppl 2(Suppl 2):ii2-ii12. PubMed ID: 15479866
    [No Abstract]   [Full Text] [Related]  

  • 32. Key developments in rheumatology.
    Panthakalam S; Pal B
    Practitioner; 2000 Dec; 244(1617):1024-6, 1029-32. PubMed ID: 11220170
    [No Abstract]   [Full Text] [Related]  

  • 33. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study.
    Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Not Available].
    Krüger K
    Dtsch Med Wochenschr; 2017 Nov; 142(23):1773-1774. PubMed ID: 29145683
    [No Abstract]   [Full Text] [Related]  

  • 35. Interstitial lung disease and disease modifying anti-rheumatic drugs.
    Scott DL
    Lancet; 2004 Apr; 363(9416):1239-40. PubMed ID: 15081669
    [No Abstract]   [Full Text] [Related]  

  • 36. Lactation and Management of Postpartum Disease.
    Bermas BL
    Rheum Dis Clin North Am; 2017 May; 43(2):249-262. PubMed ID: 28390567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. How dangerous are norovirus infections in patients with rheumatic diseases treated with biologics and DMARDs? Follow-up on a local outbreak and comparison with a control cohort.
    Fiehn C; Miehle N
    Ann Rheum Dis; 2014 Apr; 73(4):786-7. PubMed ID: 24276367
    [No Abstract]   [Full Text] [Related]  

  • 38. Was risk properly assessed in Carter, et al's safety assessment of tumor necrosis factor antagonists during pregnancy?
    Winger EE; Reed JL
    J Rheumatol; 2009 Sep; 36(9):2122; author reply 2123. PubMed ID: 19738224
    [No Abstract]   [Full Text] [Related]  

  • 39. The monitoring of patients on disease-modifying antirheumatoid drugs.
    Jones SM; Calin A
    Br J Rheumatol; 1993 Jan; 32(1):87. PubMed ID: 8422574
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacogenomics in rheumatoid arthritis.
    Ranganathan P
    Methods Mol Biol; 2008; 448():413-35. PubMed ID: 18370240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.